null

Alsevalimab Biosimilar (Anti-B7-H4) Antibody (HDBS0072)

SKU:
HDBS0072
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
B7-H4
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399

Description

system_update_altDatasheet

Alsevalimab (Anti-B7-H4) Biosimilar Antibody (HDBS0072)

The Anti-B7-H4 ALSEVALI Biosimilar (HDBS0072) is a high-quality antibody designed for research involving B7-H4, a cell surface molecule with immune regulatory functions. This biosimilar antibody, created using advanced technology, is highly specific and sensitive for detecting B7-H4 in human samples.B7-H4 is known for inhibiting immune responses and has implications in various diseases, including cancer and autoimmune disorders. By targeting B7-H4 with this biosimilar antibody, researchers can gain insights into its role in immune modulation and potentially develop new therapies for these conditions.

Validated for use in Western blot applications, this biosimilar antibody enables accurate detection and analysis of B7-H4 protein in different cell types. Its reliability and specificity make it an invaluable tool for studies in immunology and cancer research, where understanding the function of B7-H4 is crucial for advancing our knowledge of immune regulation and disease pathology.